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Abstract
Monocytes consist of two well-defined subsets, the Ly6C+ and Ly6C–monocytes. Both
CD11b+ myeloid cells populations have been proposed to infiltrate tissues during inflamma-
tion. While infiltration of Ly6C+ monocytes is an established pathogenic factor during hepat-
ic inflammation, the role of Ly6C–monocytes remains elusive. Mice suffering experimental
African trypanosome infection die from systemic inflammatory response syndrome (SIRS)
that is initiated by phagocytosis of parasites by liver myeloid cells and culminates in apopto-
sis/necrosis of liver myeloid and parenchymal cells that reduces host survival. C57BL/6
mice are considered as trypanotolerant to Trypanosoma congolense infection. We have re-
ported that in these animals, IL-10, produced among others by myeloid cells, limits the liver
damage caused by pathogenic TNF-producing Ly6C+ monocytes, ensuring prolonged sur-
vival. Here, the heterogeneity and dynamics of liver myeloid cells in T. congolense-infected
C57/BL6 mice was further dissected. Moreover, the contribution of Ly6C–monocytes to try-
panotolerance was investigated. By using FACS analysis and adoptive transfer experi-
ments, we found that the accumulation of Ly6C–monocytes and macrophages in the liver of
infected mice coincided with a drop in the pool of Ly6C+ monocytes. Pathogenic TNF mainly
originated from Ly6C+ monocytes while Ly6C–monocytes and macrophages were major
and equipotent sources of IL-10 within myeloid cells. Moreover, Nr4a1 (Nur77) transcription
factor-dependent Ly6C–monocytes exhibited IL-10-dependent and cell contact-dependent
regulatory properties contributing to trypanotolerance by suppressing the production of TNF
by Ly6C+ monocytes and by promoting the differentiation of the latter cells into macro-
phages. Thus, Ly6C–monocytes can dampen liver damage caused by an extensive Ly6C+
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monocyte-associated inflammatory immune response in T. congolense trypanotolerant ani-
mals. In a more general context, Ly6C– or Ly6C+ monocyte targeting may represent a thera-
peutic approach in liver pathogenicity induced by chronic infection.
Author Summary
The liver is not only a central organ for efficient metabolism of nutrients and for toxin
clearance, but also for immune surveillance, including elimination of intravascular infec-
tions. However, excess of nutrients like fat or of toxins like alcohol and certain medica-
tions, as well as infections can trigger overactive immune responses which destroy the
liver. Such chronic inflammations are major worldwide human health problem with often
lethal consequences. Thus, understanding the particular function of various liver immune
cells could provide original concepts to alleviate damages in this vital organ. Here, we dis-
sected the heterogeneity, dynamics and function of the myeloid/monocytic cell compart-
ment in the liver of mice infected with Trypanosoma congolense parasite. We established
that infiltration of Ly6C+ monocyte subset initiated liver injury in infected mice. More im-
portantly, we revealed that another myeloid cell subset for which the role in liver injury re-
mained elusive, the Ly6C- monocyte subset, exerted hepatoprotective function in infected
mice by secreting the anti-inflammatory cytokine IL-10 and by inducing, through cell-
contact, the differentiation of pathogenic Ly6C+ monocytes into macrophages expressing
genes coding for anti-inflammatory molecules. Thus, augmenting Ly6C- monocyte accu-
mulation or functionality may represent a useful intervention strategy complementing
anti-infective medication in conditions of liver injury due to chronic infections.
Introduction
Hosts can develop two different strategies to control pathogen infections, resistance and toler-
ance. During resistance, the host reduces the pathogen burden by activating and recruiting im-
mune cells to the site of infection that mount a pro-inflammatory immune response. Tolerance
refers to the action whereby the host repairs the tissue damage, i.e the pathogenicity, caused by
the inflammatory immune cells that mediate the resistance [1, 2]. African trypanosomes are ex-
tracellular protozoan parasites causing sleeping sickness in humans and Nagana disease in cattle
in sub-Saharan Africa. In experimental Trypanosoma congolense infection, C57BL/6 mice are
considered as "trypanotolerant", being resistant and tolerant to the disease. The resistance of
these animals results from their capacity to develop IFN-γ and MyD88-dependent CD11b+ my-
eloid cells, i.e. M1-type myeloid cells, including CCR2-dependent Ly6C+ monocytes and macro-
phages that secrete trypanotoxic molecules like TNF and NO and exert phagocytic activity to
control the parasitemia [3–9]. This control of parasite growth occurs mainly in the liver [4, 10].
However, the M1-activated Ly6C+ monocyte subpopulation negatively affects the tolerance to
T. congolense infection. Indeed, T. congolense-infected mice die from a systemic inflammatory
response syndrome that is initiated by the engulfment of parasite components by liver myeloid
cells, and culminates in apoptosis of liver myeloid cells and necrosis of liver parenchymal cells
that reduce the host survival [3, 4]. In this respect, Ly6C+ monocytes have been shown to trigger
liver cell apoptosis/necrosis, resulting in organ failure and early death by perpetuating a TNF-
mediated pro-inflammatory immune response [7, 11]. On the other hand, IL-10 does not influ-
ence the resistance but is an essential contributor to the tolerance to T. congolense infection.
Ly6C- Monocytes Are Hepatoprotective
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This cytokine has been shown to down-regulate the Ly6C+ monocyte-induced pathogenicity
and to induce regulatory, M2-type myeloid cells expressing a number of genes that could con-
tribute to tissue healing, including maintenance of liver homeostasis. Both regulatory T cells and
CD11b+ myeloid cells have been identified as sources of IL-10 during T. congolense infection in
trypanotolerant animals [7, 10, 11]. Yet, within the heterogeneous CD11b+ myeloid cell popula-
tion, the subset responsible for the IL-10 mediated anti-inflammatory immune response, thus
for trypanotolerance, remained to be identified. In this study, we reveal the mobilization of IL-
10-expressing Ly6C- monocytes and macrophages after the control of the first peak of parasite-
mia when a M2-type regulatory immune response arises in the liver of T. congolense—infected
mice. In particular, Ly6C- monocytes exerted regulatory functions through the suppression of
TNF production by Ly6C+ monocytes and by promoting the differentiation of the latter mono-
cytes into macrophages. Hereby, Ly6C- monocytes contributed to the trypanotolerance by
dampening liver damage caused by T. congolense—induced pro-inflammatory immune re-
sponse. Thus, while the liver protective function of IL-10-producing regulatory T cells is amply
documented [12–14], we have now established a similar function for Ly6C- monocytes.
Results
Trypanosome infection induces the sequential mobilization of distinct
myeloid cell subsets in the liver
The phenotype of intrahepatic CD11b+ myeloid cells during parasite-induced liver inflamma-
tion was investigated in CX3CR1-GFP
+/- C57BL/6 mice infected with T. congolense at day 7, 14
and 21 post infection (pi). Based on FACS analysis (Fig 1A, S1 Fig in S1 Text), three main cell
subsets were identified in the liver of infected mice: Ly6C+ 'inflammatory' monocytes
(CX3CR1
int CD11bhi CD115hi MHC-II- to int CD62Lhi F4/80int Mertk- CD64lo CD11c- Mar-1-),
Ly6C- 'patrolling' monocytes (CX3CR1
hi CD11bhi CD115hi MHC-II- to lo CD11ahi F4/80lo
Mertk- CD64- CD11cint Mar-1-) and macrophages (Ly6C- CD11bint CX3CR1int F4/80hi Mertk+
MHC-IIhi CD115lo CD64hi CD11c- Mar-1-) [15–19]. When addressing the dynamics of these
three distinct liver myeloid cell subsets, Ly6C+ monocytes were found to be recruited predomi-
nantly at day 7 pi (Fig 1A) when a M1-type inflammatory immune response is mounted to
control the first peak of parasitemia [4, 6], while the Ly6C- monocytes and the macrophages ac-
cumulated in the late stage of infection at day 21 pi (Fig 1A), when a M2-type/regulatory im-
mune response develops and controls the liver damage caused by the M1-type response [7, 11].
Moreover, the Ly6C+ monocytes and the macrophages mobilized in the liver of infected mice
were prominently MHC-II- to int and MHC-IIint to hi, respectively, while the MHC-II- to lo frac-
tion of the Ly6C- monocytes accumulated (Fig 1B, S2 Fig in S1 Text). As compared to blood
monocytes, liver Ly6C+ monocytes showed an increased F4/80 and MHC-II expression and a
decreased CD115 expression (Fig 1C, S2 Fig in S1 Text), suggesting their maturation upon en-
tering the liver of T. congolense-infected mice. Blood Ly6C- monocytes only exhibited de-
creased CD115 expression upon entry in the liver (Fig 1C, S2 Fig in S1 Text).
Ly6C+ monocytes differentiate into macrophages in the liver of T.
congolense-infected mice
In view of the sequential accumulation of myeloid cell subsets in the liver of infected mice (Fig
1), the turnover of Ly6C+ and Ly6C- monocytes and their relationship with the macrophage
pool was investigated. When BrdU was continuously administered in infected mice, blood
Ly6C+ monocytes became more rapidly BrdU+ than liver Ly6C+ monocytes concomitant with
the acquisition of Ki67 expression (S3 Fig in S1 Text), indicating a rapid turnover and/or
Ly6C- Monocytes Are Hepatoprotective
PLOS Pathogens | DOI:10.1371/journal.ppat.1004873 May 28, 2015 3 / 22
proliferation rate of the circulating Ly6C+ monocytes. In comparison, liver macrophages and
even more blood and liver Ly6C- monocytes showed a longer lag-phase in BrdU incorporation
and a KI67lo and Ki67- profile, respectively, pointing to a lower turnover and/or proliferation
rate of the 2 latter cell populations (S3 Fig in S1 Text). These data suggest that BrdU+ Ly6C+
monocytes can differentiate into a macrophage and/or a Ly6C- monocyte population in the
liver of infected mice. Accordingly, when Ly6C+ monocytes isolated from the liver of T. congo-
lense—infected CD45.2 LysM-GFP mice (in which myeloid cells that express LysM are labeled
with GFP; [20]) were transferred in infected CD45.1 wild-type (WT) mice, they mainly
Fig 1. Distinct liver myeloid cell subsets are sequentially mobilized in T. congolense-infected mice. Ly6C+ monocytes (Ly6C+ Mo), Ly6C- monocytes
(Ly6C- Mo) and macrophages (MF) were gated based on Ly6C and CX3CR1/GFP expression as illustrated in S1A Fig in S1 Text in non-infected (n.i) and
infected CX3CR1-GFP
+/- mice at day 7, 14 and 21 pi. Numbers of (A) the 3 myeloid cell subsets and (B) of the MHC-II- to lo and MHC-IIint to hi fraction of Ly6C+
monocytes, Ly6C- monocytes and macrophages within liver non-parenchymal cell population were determined. Data are shown as mean + SD of 3 individual
mice from one representative out of four independent experiments. * p< 0.05 compared to non-infected mice; § p<0.05 comparing populations linked by
horizontal bar. (C) F4/80 or CD115 expression on Ly6C+ monocytes, Ly6C- monocytes and macrophages from the blood or the liver at day 7 and 14 pi
determined as mean fluorescence intensity difference (dMFI) between anti-F/80 or anti-CD115 and isotype control antibodies.
doi:10.1371/journal.ppat.1004873.g001
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acquired within 72 h, a CD11bint Ly6C- MHC-II+ F4/80hi CD64lo Mertkhi but CD11c- and
Mar-1- profile (Fig 2A) representing macrophages (S1 Fig in S1 Text; [16, 18, 19]). In contrast,
Ly6C- monocytes from T. congolense—infected CX3CR1-GFP
+/- CD45.2 mice transferred in
CD45.1 mice maintained within 96 h post-transfer a CX3CR1
hi Ly6C- profile and did not ac-
quire F4/80 and MHC-II expression (S4 Fig in S1 Text). A minor fraction of the transferred
GFP+ Ly6C+ monocytes acquired a Ly6C- F4/80lo MHC-II- phenotype (Fig 2A), similar to the
Ly6C- monocyte phenotype (S1 Fig in S1 Text). These data and the longest lag-phase in BrDU
incorporation for Ly6C- monocytes observed in S3 Fig in S1 Text, suggested that Ly6C+ mono-
cytes could differentiate into Ly6C- monocytes during T. congolense-induced inflammation.
Thus, we investigated whether the reduction of circulating and liver Ly6C+ monocytes occur-
ring in CCR2-/- mice infected with African trypanosome [21] affected the presence of the other
liver myeloid cell subsets. The absence of GFP reporter gene in the CCR2-/- mice at our disposi-
tion required the setting of an alternative gating strategy to distinguish the Ly6C+ monocyte,
Fig 2. Ly6C+ monocytes differentiate into macrophages in T. congolense-infectedmice. (A) Liver GFP+ Ly6C+ monocytes (Ly6C+ Mo) purified from
CD45.2 LysM-GFPmice at day 7 pi were transferred in CD45.1WTmice at d8 pi. After 15, 36 and 72 h, liver CD45.2+ GFP+ cells from recipient mice were
analysed for CD11b and Ly6C expression. MHC-II, F4/80, Mertk, CD64, CD11c and Mar1 expression was then investigated in Ly6C- CD11b+ cells. FACS
profiles are representative of 1 out of 9 mice tested in three independent experiments. Percentages of cells in indicated gates are as shown as mean ± SD of
3 individual mice of one representative out of three independent experiments. (B) ALT levels in mice treated with Ly6C+ monocytes or with HBSS as control.
Data are shown as mean + SD of 3 individual mice of one representative out of three independent experiments. * p<0.05 compared to control mice.
doi:10.1371/journal.ppat.1004873.g002
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the Ly6C- monocyte and the macrophage cell subsets (S5A Fig in S1 Text). This strategy was
(i) based on the differential expression of CD115, Ly6C, MHC-II and F4/80 molecules by these
three cell populations reported in S1 Fig in S1 Text, and (ii) validated using CX3CR1-GFP
+/-
mice (S5B Fig in S1 Text). At day 7 and 21 pi, T. congolense-infected CCR2-/- mice exhibited
not only a lower amount of Ly6C+ monocytes, but also of Ly6C- monocytes in the blood and
the liver (S5C Fig in S1 Text), confirming that some Ly6C+ monocytes can differentiate into
Ly6C- monocytes in infected mice. The reduced amount of monocytes in infected CCR2-/-
mice coincided with a trend towards lower amount of liver macrophages (S5CFig in S1 Text).
Together, these data indicate that Ly6C+ monocytes differentiate mainly into macrophages but
also into Ly6C- monocytes in the liver of T. congolense-infected mice. In contrast, Ly6C- mono-
cytes did not acquire macrophage differentiation markers.
Liver myeloid cell subsets from trypanosome-infected mice exhibit
different activation status
The transfer of Ly6C+ monocytes at day 6 pi increased liver injury reflected by increased ala-
nine aminotransferase (ALT) serum levels in T. congolense-infected mice (Fig 2B), confirming
the pathogenic nature of these cells [21]. These cells were the major source of TNF in the liver
of infected mice (Fig 3A). Our previous research established that liver CD11b+ Ly6G- myeloid
cells contributed to IL-10 production and expressed genes associated with a M2-type activa-
tion, hereby limiting the production of hepatotoxic TNF by Ly6C+ monocytes [7, 10, 21]. In
view of the expansion of both the Ly6C- monocyte and the macrophage populations within
liver CD11b+ myeloid cells at this stage of T. congolense infection (Fig 1A), their relative contri-
bution to IL-10 production and M2-type activation was investigated at day 21 pi. As compared
to non-fractionated CD11b+ myeloid cells, the Il10 gene expression was similarly increased in
Ly6C- monocytes and macrophages, while down-regulated in Ly6C+ monocytes (Fig 3B).
Moreover, investigating the expression of genes that are induced by IL-10 in M2-type non-
fractionated CD11b+ cells during African trypanosome infection [7, 10, 22], showed that Folr2,
Ctss,Mgl2 and Sepp1 expression was upregulated in macrophages but not in the other myeloid
cell subsets from T. congolense—infected mice; Ngfb and Arg1 expression was induced to
Fig 3. Ly6C+ monocytes are the main producers of TNF while Ly6C- monocytes andmacrophages are the major source of IL-10 in T. congolense-
infectedmice. (A) Intracellular TNF+ cells were gated in liver non-parenchymal cells from CX3CR1-GFP
+/- mice at day 7 and 21 pi. The percentage of Ly6C+
monocytes (Ly6C+ Mo), Ly6C- monocytes (Ly6C- Mo), macrophages (MF) gated as in Fig 1A, and of CD11b+ Ly6G+ neutrophils and CD11b- cell was
determined within TNF+ cells. Data are shown as mean + SD of 3 individual mice from one representative out of three independent experiments. * p<0.05
compared to other populations (B) Il10 gene expression in liver Ly6C+ monocytes, Ly6C- monocytes and macrophages purified from CX3CR1-GFP
+/- mice at
day 21 pi was normalized against S12 gene expression and expressed relatively to gene expression in non-fractionated CD11b+ liver cells. Data are shown
as mean + SD of 3 individual mice from one representative out of three independent experiments. # p<0.05 compared to non-fractionated CD11b+ myeloid
cells; § p<0.05 comparing populations linked by horizontal bar.
doi:10.1371/journal.ppat.1004873.g003
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similar levels in the three myeloid cell subpopulations; and F13a1 expression was induced at
higher level in Ly6C+ monocytes than in the other myeloid cell subpopulations (S6A Fig in S1
Text). Concerning M1-type genes triggered in non-fractionated CD11b+ myeloid from T. con-
golense—infected mice [7, 10], Tnf and to lower extent Nos2 expression was upregulated main-
ly in Ly6C+ monocytes, and Ccl2, Cxcl9 and Cxcl10 expression was induced in macrophages.
With the exception of Ccl2, none of the tested genes showed induced expression in Ly6C-
monocytes compared to the non-fractionated CD11b+ myeloid cell population (S6B Fig in S1
Text). These data suggest that Ly6C- monocytes and macrophages were the main IL-10 pro-
ducers within liver CD11b+ myeloid cell subsets in the late stage of T. congolense infection.
Moreover, the three myeloid cell subsets showed differential activation status, Ly6C+ mono-
cytes expressing mainly M1-type genes, Ly6C- monocytes expressing mainly IL-10 and macro-
phages expressing a mix of M1/M2-type genes.
Ly6C- monocytes limit the production of TNF by Ly6C+ monocytes
during trypanosome-induced liver injury
The expansion of IL-10-producing Ly6C- monocytes and the decline of pathogenic TNF-
producing Ly6C+ monocytes in late stage T. congolense—infected mice prompted us to investi-
gate whether the former monocytes exerted anti-inflammatory/hepatoprotective activity. We
focused on the role of the MHC-II- to lo Ly6C- monocyte fraction since this population was
found to accumulate in the course of infection (Fig 1B; S2 Fig in S1 Text).
In in vitro co-cultures, Ly6C- monocytes purified from the liver at day 21 pi were found to
reduce the production of TNF by liver Ly6C+ monocytes isolated at day 7 pi (Fig 4A), when
their production of TNF was maximal [7, 10, 11]. To validate these data in vivo, Ly6C- mono-
cytes were sorted from T. congolense-infected CD45.2 CX3CR1-GFP
+/- mice at day 21 pi and
transferred in CD45.1 WT mice at day 4 and 6 pi. At day 7 pi, Ly6C+ monocytes from recipient
mice expressed a higher intracellular level of TNF than the CD11b+ Ly6C- cell fraction (Fig 4B)
that includes macrophages and Ly6C- monocytes (S1 Fig in S1 Text). The two latter cell popu-
lations are thus marginal contributors to TNF production as compared to Ly6C+ monocytes in
infected mice (in agreement with Fig 3A). More importantly, the intracellular production of
TNF decreased in the Ly6C+ monocyte but not in the CD11b+ Ly6C- cell fraction in recipient
mice treated with Ly6C- monocytes as compared to control-treated mice (Fig 4B). The decrease
in TNF production in Ly6C+ monocytes from recipient mice treated with Ly6C- monocytes co-
incided with a reduced production of TNF in non-parenchymal cell culture supernatants and
reduced liver damage (Fig 4C and 4D). These data suggest that Ly6C- monocytes restrained
TNF production by Ly6C+ monocytes and hereby exerted hepatoprotective function in T. con-
golense—infected mice. To support these data obtained by augmenting the Ly6C- population in
infected animals through adoptive transfer experiments, we adopted a reverse strategy, using
Nr4a1-/- mice in which Ly6C- monocytes are almost absent from the circulation due to apopto-
sis in the bone marrow [23]. Non-parenchymal liver cells from Nr4a1-/- and WTmice cultured
ex-vivo secreted similar amount of TNF. Moreover, in both mouse strains, the percentage of
TNF producing Ly6C+ monocytes and macrophages as well as their respective TNF production
were comparable (S7 Fig in S1 Text), confirming that the Nr4a1 transcription factor did not af-
fect the capacity of Ly6C+ monocytes and macrophages to secrete TNF [24]. In T. congolense—
infected Nr4a1-/- mice, the reduction of the liver Ly6C- monocyte population coincided with
the increased accumulation of Ly6C+ monocytes (Fig 5A). These cells produced more TNF
(Fig 5B), resulting in increased production of TNF in non-parenchymal cell culture superna-
tants as well as in the blood (Fig 5C and 5D), coupled with increased ALT serum levels (Fig
5E). Moreover, although the percentage of liver macrophages decreased in Nr4a1-/- mice
Ly6C- Monocytes Are Hepatoprotective
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(S8 Fig in S1 Text), no difference in their absolute number was observed (Fig 5A) due to the
higher amount of liver non-parenchymal isolated from infected Nr4a1-/- mice. The TNF pro-
duction by CD11b+ Ly6C- cells that include mainly macrophages marginally increased (Fig
5B). Furthermore, the lack of Ly6C- monocytes and the decrease in percentage of the macro-
phage population in the liver of infected Nr4a1-/- mice associated with reduced IL-10 levels in
cell culture supernatants and in blood (Fig 5F and 5G), confirming these two cell types as po-
tential sources of IL-10 in T. congolense—infected mice (Fig 3B).
Fig 4. Ly6C- monocytes limit TNF production by Ly6C+ monocytes in T. congolense-infected mice. (A) Liver Ly6C+ monocytes (Ly6C+ Mo) and
MHC-II- to lo Ly6C- monocytes (Ly6C- Mo) purified from CX3CR1-GFP
+/- mice at day 7 pi and 21 pi, respectively, were cultured at indicated ratio. TNF
concentration in cell supernatants was measured. Data are shown as mean + SD of 1 representative out of five independent experiments. * p<0.05
compared to Ly6C+ monocytes cultured alone. (B-D) Liver MHC-II- to lo Ly6C- monocytes purified from CD45.2 CX3CR1-GFP
+/- mice at day 21 pi were
transferred in CD45.1WTmice at day 4 and day 6 pi. Control mice received HBSS. Different parameters were evaluated in recipient mice at d7 pi: (B)
Spontaneous TNF levels in liver Ly6C+ monocytes (left panel) and CD11b+ Ly6C- cells (right panel) from control or Ly6C- monocyte-treated mice
determined as mean fluorescence intensity difference (dMFI) between anti-TNF and isotype control antibodies. (C) Spontaneous TNF concentration in
supernatants of liver non-parenchymal cell cultures and (D) serum alanine aminotransferase (ALT) levels. Data are shown as mean + SD of 3 individual mice
of one representative out of three independent experiments. * p<0.05 compared to control mice.
doi:10.1371/journal.ppat.1004873.g004
Ly6C- Monocytes Are Hepatoprotective
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IL-10 contributes to the Ly6C- monocyte-regulatory activity during
trypanosome infection
Ly6C- monocytes could contribute to the production of IL-10 in T. congolense—infected mice
(Fig 3; Fig 5F and 5G) and limit the production of TNF by Ly6C+ monocytes (Fig 4A–4C; Fig
5B–5D). Therefore, we investigated whether the limitation of TNF production by Ly6C- mono-
cytes was mediated by IL-10. Two types of experiments were performed.
First, TNF production was monitored in co-cultures containing liver Ly6C- and Ly6C+
monocytes sorted frommice at day 21 and day 7 pi, respectively, in the presence of neutralizing
anti-IL-10R antibody (Fig 6A). Blocking the IL-10R signaling ablated the limitation of TNF
production observed when Ly6C+ monocytes were cultured with Ly6C- monocytes. In contrast,
IL-10R signaling neutralization had no effect on the production of TNF when Ly6C+ mono-
cytes were cultured alone.
Second, liver Ly6C- monocytes were isolated at day 21 pi from CD45.2 T. congolense—
infected IL-10flox/flox LysM-cre+/+ mice, which lack IL-10 production specifically in LysM-
expressing myeloid cells and hereby exhibit increased TNF levels and increased liver damage
[7, 25]. These cells were adoptively transferred in CD45.1 WT mice at day 4 and 6 pi and the
intracellular production of TNF by liver Ly6C+ monocytes was investigated at day 7 pi. As
shown in Fig 6B, TNF production was impaired to a greater extent in recipient mice treated
with Ly6C- monocytes from control IL-10wt/wt LysM-cre+/+ mice than in recipient mice treat-
ed with Ly6C- monocytes from IL-10flox/flox LysM-cre+/+ mice. Moreover, the secretion of
TNF was reduced in cell culture supernatants of recipient mice treated with Ly6C- monocytes
from control IL-10wt/wt LysM-cre+/+ mice but not from IL-10flox/flox LysM-cre+/+ mice (Fig
6C). Finally, ALT levels were reduced in recipient mice treated with Ly6C- monocytes from
control IL-10wt/wt LysM-cre+/+ mice but not from IL-10flox/flox LysM-cre+/+ mice (Fig 6D).
Together these data suggest that Ly6C- monocytes could hamper TNF production by Ly6C+
monocytes partly via their IL-10 production and hereby reduce liver injury in T. congolense—
infected mice.
Fig 5. Depletion of Ly6C- monocytes in Nr4a1-/- mice increases TNF production and liver damage in T. congolense—infectedmice.Different
parameters were evaluated in WT and Nr4a1-/- mice at day 21 pi. Liver Ly6C+ monocytes (Ly6C+ Mo), Ly6C- monocytes (Ly6C- Mo) and macrophages (MF)
were gated as in S5A Fig in S1 Text. (A) Numbers of Ly6C+ monocytes, Ly6C- monocytes and macrophages within liver non-parenchymal cell population.
(B) Spontaneous TNF levels in Ly6C+ monocytes and CD11b+ Ly6C- cells determined as mean fluorescence intensity difference (dMFI) between anti-TNF
and isotype control antibodies. (C,D) TNF and (F,G) IL-10 concentration in (C,F) supernatants of liver non-parenchymal cell cultures or (D,G) in blood serum.
(E) ALT levels in blood serum. Data are shown as mean + SD of 3 individual mice of one representative out of five independent experiments. *p<0.05
compared to WTmice.
doi:10.1371/journal.ppat.1004873.g005
Ly6C- Monocytes Are Hepatoprotective
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Ly6C- monocytes promote the differentiation of Ly6C+ monocytes into
macrophages during trypanosome-induced liver inflammation
Transfer experiment of Ly6C+ monocytes in recipient mice suggested that a fraction of the
liver macrophages in T. congolense—infected mice originate from Ly6C+ monocytes (Fig 2A).
Moreover, the liver macrophage population reduced while the Ly6C+ cell population increased
in infected Nr4a1-/- mice lacking Ly6C- monocytes (S8 Fig in S1 Text). In contrast, in infected
mice treated with Ly6C- monocytes, the Ly6C- CX3CR1
int macrophage population increased
(Fig 7A). Therefore, we investigated whether Ly6C- monocytes shaped by T. congolense infec-
tion could favor the differentiation of Ly6C+ monocytes into macrophages. We used Ly6C-
monocytes from day 21 pi because their clear accumulation at that stage of infection coincided
with increased macrophage accumulation (Fig 1A) and with a shift from a pathogenic to anti-
pathogenic immune response required for trypanotolerance [7, 10, 11]. GFP+ Ly6C+ mono-
cytes isolated from LysM-GFP mice at day 7 pi were adoptively transferred, with or without
Ly6C- monocytes isolated from CD45.2 mice at day 21 pi, in recipient CD45.1 WT mice at day
12 pi. Liver CD45.2+ GFP+ cells were characterized 48 h later (Fig 7B). In mice that were not
treated with Ly6C- monocytes, 45 ± 4.6% of the GFP+ monocytes differentiated into Ly6C-
CD11bint MHC-II+ cells (Fig 7B) that represented macrophages (S1 Fig in S1 Text). These per-
centages increased to 73 ± 8.7% in mice treated with Ly6C- monocytes (Fig 7B). TNF produc-
tion decreased and IL-10 production increased in non-parenchymal cell culture supernatants
from mice treated with Ly6C- monocytes, and serum ALT level decreased (Fig 7C–7E). These
Fig 6. Ly6C- monocytes through IL-10 production limit TNF production by Ly6C+ monocytes in T. congolense-infectedmice. (A) Liver Ly6C+
monocytes (Ly6C+ Mo) and MHC-II- to lo Ly6C- monocytes (Ly6C- Mo) purified from CX3CR1-GFP
+/- mice at day 7 pi and 21 pi, respectively, were cultured
alone or together at indicated ratio in presence of control (-) or neutralising anti-IL-10R antibody. TNF concentration in cell supernatants was measured. Data
are shown as mean + SD of 1 out of five independent experiments. * p<0.05 compared to Ly6C+ monocytes cultured alone, § p<0.05 comparing populations
linked by horizontal bar. (B-D) Liver MHC-II- to lo Ly6C- monocytes gated as described in Fig 5A in S1 Text purified from IL-10wt/wt LysM-cre+/+ or IL-10flox/flox
LysM-cre+/+ mice at day 21 pi were transferred in CD45.1 WTmice at day 4 and day 6 pi. Control mice received HBSS. Different parameters were evaluated
in recipient mice at day 7 pi: (B) TNF levels in liver Ly6C+ monocytes determined as mean fluorescence intensity difference (dMFI) between anti-TNF and
isotype control antibodies, (C) Spontaneous TNF concentration in liver non-parenchymal cell culture supernatants, and (D) ALT levels in blood serum. Data
are shown as mean + SD of 3 individual mice of one representative out of three independent experiments. § p<0.05 comparing populations linked by
horizontal bar.
doi:10.1371/journal.ppat.1004873.g006
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data suggest that in the liver of T. congolense—infected mice, Ly6C- monocytes promote the
differentiation of Ly6C+ monocytes into macrophages and switch the cytokine milieu from
hepatodestructive to hepatoprotective. This finding was confirmed by transferring GFP+
Ly6C+ monocytes or GFP+ Ly6C+ monocytes plus Ly6C- monocytes isolated from infected
WTmice in Nr4a1-/- recipients that do not produce Ly6C- monocytes (Fig 8A). In mice co-
treated with Ly6C- monocytes, the percentage of liver GFP+ cells that gained F4/80 and
MHC-II expression and lowered their expression of CD11b, reflecting a differentiation towards
macrophages, increased and coincided with reduced TNF and ALT level as well as with in-
creased IL-10 level (Fig 8A–8D).
Fig 7. Ly6C- monocytes induce differentiation of Ly6C+ monocytes into macrophages in T. congolense-infectedWTmice. (A) Liver MHC-II- to lo
Ly6C- monocytes (Ly6C- Mo) purified from CX3CR1-GFP
+/- mice at day 21 pi were transferred in CD45.1WTmice at day 4 and day 6 pi. Control mice
received HBSS. At day 7 pi, percentages of Ly6C+ monocytes (Ly6C+ Mo), Ly6C- monocytes (Ly6C- Mo) and macrophages (MF) within liver non-
parenchymal cells were determined in recipient mice. Data are shown as mean + SD of 3 individual mice of one representative out of three independent
experiments. *p<0.05 compared to control mice. (B)GFP+ Ly6C+ monocytes purified from CD45.2 LysM-GFPmice at day 7 pi were transferred in CD45.1
WTmice at day 12 pi with or without MHC-II-to lo Ly6C- monocytes gated as described in S5A Fig in S1 Text and purified from CD45.2 WTmice at day 21 pi.
After 48 h, liver CD45.2+ GFP+ cells in recipient mice were analyzed for CD11b and Ly6C expression. MHC-II expression was then investigated in Ly6C-
CD11b+ cells. FACS profiles are representative of 1 out of 9 mice tested in three independent experiments. Percentages of cells in indicated gates are shown
as mean ± SD of 3 individual mice of one representative out of three independent experiments. (C) TNF and (D) IL-10 concentration in supernatants of liver
non-parenchymal cell cultures from recipient mice. (E) ALT levels in blood serum from recipient mice. Data are shown as mean + SD of 3 individual mice of
one representative out of three independent experiments. *p<0.05 compared to recipient mice receiving only Ly6C+ monocytes.
doi:10.1371/journal.ppat.1004873.g007
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To address a mechanistic basis for how Ly6C- monocytes could promote the differentiation
of Ly6C+ monocytes into macrophages, Ly6C+ monocytes and GFP+ Ly6C- monocytes purified
from T. congolense-infected mice at day 6 and 21 pi, respectively, were co-cultured with and
without a transwell plate. The Ly6C+ cell differentiation to macrophages was investigated after
7 days, gating out the GFP+ cells (Fig 9A). The GFP- cell population exhibited reduced expres-
sion of Ly6C and increased expression of F4/80, MerTK, CD64 and MHC-II, reflecting macro-
phage differentiation of the Ly6C+ monocytes, yet only when the two monocyte populations
were in contact. The capacity of Ly6C- monocytes to inhibit the production of TNF by Ly6C+
monocytes was also partially ablated when the two cell populations were separated from each
other (Fig 9B). Thus, a cell contact between the Ly6C+ and the Ly6C- monocytes contributed to
the differentiation of Ly6C+ cells into macrophages and to the inhibition of TNF production.
Fig 8. Ly6C- monocytes induce differentiation of Ly6C+ monocytes into macrophages in T. congolense-infected Nr4a1-/- mice that lack
endogenous Ly6C- monocytes. (A)GFP+ Ly6C+ monocytes (Ly6C+ Mo) purified from CD45.2 LysM-GFPmice at day 7 pi were transferred in CD45.2
Nr4a1-/- mice at day 12 pi with or without MHC-II-to lo Ly6C- monocytes (Ly6C- Mo) gated as described in Fig 5A in S1 Text and purified from CD45.2WTmice
at day 21 pi. After 48 h, liver GFP+ cells in recipient mice were analyzed for CD11b and F4/80 expression. MHC-II expression was then investigated in
CD11b+ F4/80+ cells. FACS profiles are representative of 1 out of 9 mice tested in three independent experiments. Percentages of cells in indicated gates are
shown as mean ± SD of 3 individual mice of one representative out of three independent experiments. (B) TNF and (C) IL-10 concentration in supernatants of
liver non-parenchymal cell cultures from recipient mice. (D) ALT levels in blood serum from recipient mice. Data are shown as mean + SD of 3 individual mice
of one representative out of three independent experiments. *p<0.05 compared to recipient mice receiving only Ly6C+ monocytes.
doi:10.1371/journal.ppat.1004873.g008
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Discussion
Dynamics of liver myeloid cells in infected mice
As in other life-threatening liver inflammation models [26–28], liver cell necrosis is thought to
be mainly mediated by TNF-producing Ly6C+ monocytes during experimental T. congolense
infection in trypanotolerant C57BL/6 mice [7]. However, in trypanotolerant mice infected
with this intravascular parasite, an IL-10-dependent, Foxp3+ Treg and CD11b+ myeloid cell-
mediated immune response develops after the control of the first peak of parasitemia to regu-
late the inflammatory condition, hereby preserving liver integrity and preventing early death
of the host. In this regard, our reported data suggest that myeloid cell-derived IL-10 only deac-
tivates the pathogenic activity of M1-type Ly6C+ monocytes while Tregs affected both patho-
genic T cells and myeloid cells [7, 11, 29]. Here, the heterogeneity and dynamic of liver
myeloid cells in T. congolense-infected mice was further detailed. We now report that the
Fig 9. Differentiation of Ly6C+ monocytes into macrophages requires a physical contact with Ly6C- monocytes. (A) Ly6C+ monocytes (Ly6C+ Mo)
purified from T. congolense-infected CD45.2 WTmice at day 6 pi were cultured alone or with MHC-II- to lo Ly6C- monocytes (Ly6C- Mo) purified from infected
CD45.2 LysM-GFPmice at day 21 pi (1: 1 ratio). Similar cultures were performed in transwell plates. Expression of Ly6C, F4/80, Mertk, CD64 or MHC-II
(white line) was investigated 7 days later on GFP- Ly6C+ monocyte-derived cells gated as in S5A Fig in S1 Text (grey line: isotype control). Results are
representative of 1 out of 9 mice tested in 3 independent experiments. (B) TNF concentration in cell culture supernatants was measured. Data are shown as
mean + SD of 1 representative out of three independent experiments. * p<0.05 compared to Ly6C+ monocytes cultured alone; § p<0.05 comparing
populations linked by horizontal bar.
doi:10.1371/journal.ppat.1004873.g009
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mounted anti-inflammatory immune response was concomitant with the mobilization/accu-
mulation in the liver of Ly6C- monocytes (CX3CR1
hi CD11bhi CD115hi CD11ahi F4/80lo
CD64- CD11cint) and macrophages (CX3CR1int CD11bint F4/80hi CD115lo CD64hi CD11c-)
coupled with a decreased presence of Ly6C+ monocytes (CX3CR1
int CD11bhi CD115hi
CD62Lhi F4/80int CD64lo CD11c-). The Ly6C+ monocytes and the macrophages mobilized in
the liver of infected mice were prominently MHC-II- to int and MHC-IIint to hi, while the
MHC-II- to lo fraction of Ly6C- monocytes mounted up. The switch from Ly6C+ monocytes to
Ly6C- monocytes and macrophages in the course of T. congolense infection reflected the
change from a TNF, hepatodestructive to an IL-10, hepatoprotective milieu [11]. Accordingly,
we show that Ly6C+ monocytes were the main producers of TNF in infected mice while Ly6C-
monocytes and macrophages contribute to IL-10 gene and protein expression. A similar se-
quential mobilization of TNF+ Ly6C+ and IL-10+ Ly6C- myeloid cell subsets in the acute and
chronic phase of various inflammation models has been highlighted [30–33].
Fate and function of Ly6C- monocytes in infected mice
It is commonly agreed that circulating Ly6C+ and Ly6C- monocytes—depending on the patho-
genic insult, their fate, timing of recruitment and location—exert tissue beneficial or detrimen-
tal functions. Hereby, Ly6C+ monocytes can infiltrate a variety of inflamed tissues, where they
down-regulate their Ly6C expression and differentiate into M1- or M2-type macrophages that
exert destructive or protective function in the initiation or resolving phase of inflammation, re-
spectively [31–37]. Similarly, tissue-accumulating Ly6C- monocytes can exert healing or dam-
aging activity in different models of sterile and non-sterile inflammation [38–41]. While it was
proposed that Ly6C- monocytes can differentiate into macrophages or DCs in inflamed tissues
[32, 38–43], it is now commonly agreed that even in steady state condition Ly6C- monocytes
are not bona fide monocytes but represent terminally differentiated "housekeeper" blood-
resident macrophages crawling along the endothelium of the vessels [19, 38, 42, 44–47].
Using adoptive transfer experiments, we evidenced the differentiation of Ly6C+ monocytes
mainly into Ly6C- F4/80hi Mertkhi MHC-II+ CD11c- Mar-1- macrophages in the liver of T. con-
golense trypanotolerant mice (Fig 10). This differentiation pathway thus differed from the
more commonly acknowledged differentiation of Ly6C+ monocytes into TIP DCs evidenced in
trypanosusceptible mice or in bacterial infection [48, 49]. Similarly, in fibrotic liver, fibrogenic
Ly6C+ monocytes rapidly differentiate into Ly6C- "restorative" macrophages [33, 50]. More-
over, using BudU labelling, adoptive transfer experiments and CCR2-/- mice, we confirmed
that circulating CCR2-dependent Ly6C+ monocytes could also partially give rise to Ly6C-
monocytes in this inflammatory setting [19, 42, 44, 45]. The Ly6C- monocytes that expanded
during T. congolense infection did not seem to differentiate into macrophages or DCs as sug-
gested by their lower ex situ expression of Pu1, Cmaf andMafb genes and their low level of
MHC-II molecule expression, as well as by maintenance of their F4/80- MHC-II- to lo pheno-
type after transfer in infected animals. However, we did not exclude that these cells were termi-
nally differentiated macrophages [18, 19, 42, 44].
Very limited data exist about the functional role of Ly6C- monocytes in the outcome of liver
inflammation [51]. These cells do not seem to be mobilized in the liver during fibrosis progres-
sion [50], but a recent report suggests that the intrahepatic Ly6C- monocyte population in-
creases in a model of non-alcoholic fatty liver disease (NAFLD) provided mice receive a drug
treatment that ameliorates the disease by decreasing inflammation [52]. We report here that
that the liver Ly6C- monocyte population expanded during T. congolense infection and exerted
a hepatoprotective/restorative function. Indeed, the absence of Ly6C- monocytes in infected
Nr4a1-/- mice resulted in higher TNF production and increased liver damage. In contrast,
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treatment of infected WT or Nr4a1-/- mice with Ly6C- monocytes triggered the differentiation
of Ly6C+ monocytes into macrophages, limited TNF production, resulting in hepatoprotection.
The limiting effect of Ly6C- monocytes on TNF production by Ly6C+ monocytes was partially
mediated by cell contact and by IL-10 (Fig 10). Indeed, the inhibition of TNF production was
partially restored when the Ly6C+ monocytes and Ly6C- monocytes were physically separated.
Moreover, the treatment of infected mice with Ly6C- monocytes from control IL-10wt/wt
LysM-cre+/+ mice reduced the production of TNF by Ly6C+ monocytes and the liver damage
more efficiently than the treatment with Ly6C- monocytes from IL-10flox/flox LysM-cre+/+ mice
lacking IL-10 gene expression in myeloid cells. Furthermore, the capacity of Ly6C- monocytes
to differentiate Ly6C+ monocytes into macrophages also required a cell contact. In this regard,
PD-L1 or PD-1 surface expression by Ly6C- monocytes was reported to trigger tolerogenic
Fig 10. Overview of the interactions between Ly6C+monocytes, Ly6C- monocytes andmacrophages contributing to trypanotolerance. TNF-
producing Ly6C+ monocytes contribute to liver injury in T. congolense-infected mice. Ly6C- monocytes hamper the pathogenic activity of Ly6C+ monocytes
through (1) IL-10 production and (2) cell contact that trigger the differentiation of Ly6C+ monocytes into restorative macrophages. Whether IL-10 possibly
produced by monocyte-derived macrophages (dashed lines) contribute to hepatoprotective activity is not elucidated.
doi:10.1371/journal.ppat.1004873.g010
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immune response [53, 54]. Moreover, soluble mediators like M-CSF, GM-CSF, IL-6, TGF-β,
PGE2 and retinoic acid could contribute to the differentiation of Ly6C+ monocytes into macro-
phages and/or to inhibition of TNF production [32, 55–60].
The Ly6C+ monocytes, Ly6C- monocytes and macrophages from T. congolense-infected
mice exhibited a differential activation status. Ly6C+ monocytes expressed mainly M1-type
genes, Ly6C- monocytes expressed mainly IL-10 and macrophages expressed a mix of M1- and
M2-type genes. Such a mixed expression of M1- and M2-type genes was previously associated
with the restorative phenotype of anti-fibrotic liver macrophages [33]. The distinct gene profile
of Ly6C- monocytes and macrophages suggested that these cells exerted different functions in
protecting the liver against T. congolense-induced injury. In this regard, macrophages expand-
ing in the liver of T. congolense—infected mice expressed higher level than Ly6C- monocytes of
the M2-type gene selenoprotein P (Sepp1), that we documented to exert anti-oxidant hepato-
protective function during infection [10]. We could not ascertain directly that Ly6C+ mono-
cyte-derived macrophages developed a restorative activation program in vivo because the low
amount of adoptively transferred cells homing in the liver of infected mice did not consent
their purification. Of note, it has become evident in the recent years that upon sterile and non-
sterile inflammation, monocyte subsets originating from bone marrow and their derived mac-
rophages complement the long-lived tissue-resident macrophage pool that originate from em-
bryonic precursors [44, 61–64]. The current view is that in inflamed tissue, the resident
macrophage pool restores homeostasis by local proliferation, by adopting a M2-type activation
status and by secreting IL-10 [65–67]. Thus, besides monocyte-derived macrophages, tissue-
resident macrophages are candidates to develop a restorative activation program during the
late stage of T. congolense infection. However, no definitive reporter mice currently allow to
discriminate the liver resident macrophages from the recruited monocyte-derived macro-
phages, hampering investigating their particular role, including M1/M2-type activation and
proliferative status, in tissue pathogenicity.
In conclusion, we reveal that in the liver of T. congolense-infected mice Ly6C- monocytes
and macrophages were major sources of the anti-pathogenic cytokine IL-10. Ly6C- monocytes
exerted a hepatoprotective function through their IL-10 production and through cell-contact
by limiting the TNF production by pathogenic Ly6C+ monocytes and by inducing the differen-
tiation of the latter cells into restorative macrophages.
Materials and Methods
Ethic statement
Experiments, maintenance and care of mice complied with guidelines of the European Con-
vention for the Protection of Vertebrate Animals used for Experimental and other Scientific
Purposes (CETS n°123) and were approved by the Ethical Committee for Animal Experiments
of the Vrije Universiteit Brussel, Brussels, Belgium (laboratory accreditation number 121 0220,
project number 11-220-12).
Mice, parasites, infections
CD45.2 C57BL/6 mice: CX3CR1-GFP
+/+ mice were bred in house with CD45.2 WT mice pur-
chased from Janvier, France to obtain CX3CR1-GFP
+/- mice. IL-10flox/flox mice kindly donated
by Dr. A. Roers (Department of Immunology, Technical University of Dresden, Germany)
were crossed with IL-10wt/wt LysM-cre+/+ mice (Jackson Laboratory, USA) to generate IL-
10flox/flox LysM- cre+/+ mice. LysM-GFP mice, kindly provided by Dr. T. Graf (Center for Ge-
nomic Regulation, Barcelona, Spain) and Nr4a1 (Nur77)-/- mice were bred in house. CD45.1
WT C57BL/6 mice were bred in-house.
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T. congolense variant antigen type 13 (Tc13, kindly provided by Dr. H. Tabel, University of
Saskatchewan, Canada) stored at -80°C were injected in cyclophosphamide-treated WT
C57BL/6 mice. At day 4 post infection, mice were bled, parasites were purified by diethyl-
aminoethyl-cellulose chromatography and used to infect experimental female, age-matched
(8–14 weeks) mice (2000 parasites/mouse, ip).
Isolation of liver non-parenchymal immune cells and adoptive transfer of
monocytes
Animals were euthanized (CO2) and livers were perfused through the portal vein with 10 ml of
120 U/ml collagenase type III (Worthington Biochemical Corporation) in HBSS (Gibco).
Then, liver was disrupted mechanically and incubated in 10 ml of a 100 U/ml collagenase III
solution in HBSS (25 min, 37°C). The resulting cell suspension was passed through a 70-μm
nylon mesh filter and washed by adding 40 ml of HBSS supplemented with 10% FCS and 2
mM EDTA (HBSS/FCS/EDTA) followed by centrifugation (300 g, 8 min, 4°C). After erythro-
cyte lysis (0.83% NH4Cl in 0.01M Tris-HCl, pH 7.2), the pellet was resuspended in 10 ml of
Lymphoprep (Lucron Bioproducts) and overlaid with 10 ml HBSS/FCS/EDTA. After centrifu-
gation (430 g, 30 min, 20°C), the layer of low-density cells at the interface containing liver non-
parenchymal cells was harvested, washed with HBSS containing 10% FCS (HBSS/FCS) and
centrifuged (300 g, 10 min, 4°C). Cells were resuspended in HBSS/FCS, counted while exclud-
ing dead cells using trypan blue and diluted to working concentrations (5 x 106/ml). Liver im-
mune cells and buffers were kept on ice during isolation protocols and subsequent analysis.
CD11b+ Ly6C+ Ly6G+ granulocytes were not retained within the non-parenchymal fractions
due to their high-density characteristic.
At indicated time-points post infection, unfractionated CD11b+ liver immune cells were iso-
lated using magnetic separation columns according to the manufacturer’s protocol (Miltenyi
Biotec). BD FACSAria II (BD Biosciences) was then used to sort from CD11b+ cells, Ly6C-
monocytes from CX3CR1-GFP
+/- (CD11bhi MHC-II- CX3CR1
hi), Ly6C- monocytes fromWT,
IL-10wt/wt LysM-cre+/+ or IL-10flox/flox LysM-Cre+/+ mice (CD11bhi CD115+ MHC-II-) or
Ly6C+ monocytes from CX3CR1-GFP
+/-, WT or LysM-GFP mice (CD11bhi CD115+). Macro-
phages were sorted from CD11b+ cells of CX3CR1-GFP
+/- mice as CD115+ F4/80hi Ly6C-
CX3CR1
int cells.
For adoptive transfer experiments, recipient mice were treated iv with Ly6C- monocytes or
Ly6C+ monocytes (8 x 105 cells/mouse). Control mice were treated with HBSS. One day after
the last transfer, liver immune cells were isolated and intracellular spontaneous production of
TNF in Ly6C+ CD11b+ monocytes and Ly6C- CD11b+ cells was analyzed by FACS. In addi-
tion, liver immune cells were cultured for 24 h and TNF concentration in supernatants
was measured.
Cell cultures and supernatants
At indicated time-points post infection, liver immune cells (2 x 106/ml, 24-well plates) were cul-
tured in RPMI 1640 (Gibco) supplemented with 10% FCS, 100 U/ml penicillin, 100 mg/ml
streptomycin, 0.1 mM non-essential amino acids, 2 mM L-glutamine (all from Invitrogen Life
Technologies). Alternatively, Ly6C+ and Ly6C- monocytes were cultured at indicated ratio in
200 μl (96-well plates). Cell supernatants were collected 1 day later. When required, cultures
were treated with 3 μg/ml of anti-IL10R antibody (clone 1B1.3a, kindly provided by Dr. O. Leo,
ULB, Gosselies, Belgium) or control antibody (rat IgG1, BD Biosciences). For in vitro macro-
phage differentiation test, liver sorted Ly6C+ monocytes (2 x 105) and GFP+ Ly6C- monocytes (2
x 105) were cultured without adding M-CSF in 200 μl medium. Cells and supernatants were
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harvested 7 days later. When required, Ly6C+ monocytes and GFP+ Ly6C- monocytes were plat-
ed in the bottom and upper compartments of transwell plates (Costar, 0.4 μm), respectively.
Quantification of cytokines
TNF and IL-10 was quantified in cell supernatants or in blood serum using specific sandwich
ELISAs (R&D Systems), in accordance to the manufacturers’ protocols.
Extracellular and intracellular FACS analysis
For extracellular stainings, liver immune cells (106) were transferred in FACS tubes and stained
for 20 min in ice-cold HBSS supplemented with 0.5% FCS using conventional protocols. Cells
were pre-incubated with anti-FcγR antibody before adding commercial labeled surface marker
antibodies (S1 Table in S1 Text). For intracellular stainings, cells (Ly6C+ CD11b+ monocytes,
Ly6C- CD11b+ cells) were cultured 4 h with brefeldin A (BD Biosciences), subsequently fixed
and permeabilized following the manufacturer's instructions (BD Biosciences). Cells were then
stained with PE-conjugated anti-TNF (clone MP6-XT22) or IgG1κ isotype control (R3-34) an-
tibody and washed with ice-cold PBS. Cells were analyzed on a FACSCanto II (BD Biosciences).
Delta-Median Fluorescence Intensity (dMFI) was calculated as difference between MFI of anti-
TNF and isotype control antibody staining. Analyses were performed using FlowJo software.
Quantitative real-time PCR
RNA extracted using the RNeasy plus mini kit (Qiagen) was reverse-transcribed with oligo
(dT) and SuperScript II RT (Invitrogen), following the manufacturer's instructions. Quantita-
tive real-time PCR was performed in an iCycle, with iQ SYBR Green Supermix (Bio-Rad).
Primer sequences are listed in S2 Table in S1 Text. PCR cycles consisted of 1-minute denatur-
ation at 94°C, 45-second annealing at 55°C, and 1-minute extension at 72°C. Gene expression
was normalized using ribosomal S12 (Mrps12) protein as a housekeeping gene.
Alanine aminotransferase (ALT) levels
ALT levels were measured in serum samples using a commercial kit (Boehringer).
Statistical analysis
All comparisons were tested for statistical significance using the unpaired t test from GraphPad
Prism 4.0 software.
Supporting Information
S1 Text. Contains S1 Table (Antibodies used for flow cytometry analysis) and S2 Table (Prim-
ers used for RT-PCR analyses) as supplement to Experimental procedures. The S1 Text con-
tains also S1 Fig (Liver myeloid cells consist of 3 distinct populations in T. congolense-infected
mice), S2 Fig (MHC-II expression on monocytes and macrophages from non-infected and in-
fected mice), S3 Fig (BrdU and Ki67 labeling of monocytes and macrophages from infected
mice), S4 Fig (Ly6C- monocytes do not differentiate into macrophages in infected mice), S5
Fig (Accumulation of liver macrophages and Ly6C- monocytes depends on CCR2 signalling in
infected mice), S6 Fig (M2-type and M1-type gene expression levels in monocytes and macro-
phages from infected mice), S7 Fig (TNF production by non-parenchymal cells, Ly6C+ mono-
cytes and macrophages from Nr4a1-/- mice), S8 Fig (Percentage within non-parenchymal cells
of monocytes and macrophages in infected Nr4a1-/-, WT and CCR2-/- mice).
(PDF)
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